Status: Phase 2
Entry Type: Unknown
Molecule Category: UNKNOWN

Pharmacology

Primary Target
3-phosphoinositide dependent protein kinase 1
checkpoint kinase 1
cyclin dependent kinase 1
LCK proto-oncogene, Src family tyrosine kinase
microtubule affinity regulating kinase 1
mitogen-activated protein kinase 14
protein kinase C alpha
protein kinase C beta
protein kinase C gamma

Indications

Mesh Heading Maximum Phase Reference
Melanoma Phase 2 ClinicalTrials
Leukemia; Lymphoma Phase 1 ClinicalTrials
Adenocarcinoma; Pancreatic Neoplasms Phase 1 ClinicalTrials
Neoplasms Phase 1 ClinicalTrials
Carcinoma, Ovarian Epithelial; Fallopian Tube Neoplasms; Ovarian Neoplasms Phase 2 ClinicalTrials
Neoplasms Phase 1 ClinicalTrials
Fallopian Tube Neoplasms; Peritoneal Neoplasms Phase 1 ClinicalTrials
Neoplasms Phase 1 ClinicalTrials
Neoplasms Phase 1 ClinicalTrials
Anus Neoplasms; Bile Duct Neoplasms; Breast Neoplasms; Brenner Tumor; Carcinoid Tumor; Carcinoma; Carcinoma, Adenoid Cystic; Carcinoma, Basal Cell; Carcinoma, Mucoepidermoid; Carcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; Carcinoma, Squamous Cell; Carcinoma, Verrucous; Cholangiocarcinoma; Colonic Neoplasms; Endometrial Neoplasms; Esophageal Neoplasms; Esthesioneuroblastoma, Olfactory; Gallbladder Neoplasms; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Germinoma; Granuloma; Head and Neck Neoplasms; Intestinal Neoplasms; Laryngeal Diseases; Laryngeal Neoplasms; Leiomyosarcoma; Liver Neoplasms; Lung Neoplasms; Malignant Carcinoid Syndrome; Nasopharyngeal Carcinoma; Neoplasms; Neoplasms, Germ Cell and Embryonal; Neoplasms, Unknown Primary; Oropharyngeal Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Papilloma; Papilloma, Inverted; Paranasal Sinus Neoplasms; Prostatic Neoplasms; Rectal Neoplasms; Salivary Gland Neoplasms; Small Cell Lung Carcinoma; Stomach Neoplasms; Triple Negative Breast Neoplasms; Uterine Cervical Neoplasms Phase 1 ClinicalTrials
Lymphoma Phase 1 ClinicalTrials
Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Lymphoma Phase 1/Phase 2 ClinicalTrials
Pancreatic Neoplasms Phase 2 ClinicalTrials
Neoplasms Phase 1 ClinicalTrials
Lung Neoplasms; Small Cell Lung Carcinoma Phase 2 ClinicalTrials
Carcinoma, Renal Cell; Kidney Neoplasms Phase 2 ClinicalTrials
Leukemia; Lymphoma Phase 1 ClinicalTrials
Blast Crisis; Leukemia; Leukemia, Erythroblastic, Acute; Leukemia, Lymphoid; Leukemia, Megakaryoblastic, Acute; Leukemia, Monocytic, Acute; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Leukemia, Myeloid, Accelerated Phase; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Myelodysplastic-Myeloproliferative Diseases; Myelodysplastic Syndromes; Myeloproliferative Disorders; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Preleukemia; Syndrome Phase 1 ClinicalTrials
CONTENTS